This is in agreement with previous studies that have documented a reduction in cardiomyocyte apoptosis following DEX treatment in the context of myocardial infarction, as evidenced by an increase in the Bcl-2/Bax ratio [26], as well as in I/R-induced cardiomyocyte injury [27]. The gene discussed is BCL2; the disease is myocardial infarction.